Literature DB >> 22874667

S-nitrosylation of Cdk5: potential implications in amyloid-β-related neurotoxicity in Alzheimer disease.

Jing Qu1, Tomohiro Nakamura, Emily A Holland, Scott R McKercher, Stuart A Lipton.   

Abstract

Aberrant activation of Cdk5 has been implicated in the process of neurodegenerative diseases such as Alzheimer's disease (AD). We recently reported that S-nitrosylation of Cdk5 (forming SNO-Cdk5) at specific cysteine residues results in excessive activation of Cdk5, contributing to mitochondrial dysfunction, synaptic damage, and neuronal cell death in models of AD. Furthermore, SNO-Cdk5 acts as a nascent S-nitrosylase, transnitrosylating the mitochondrial fission protein Drp1 and enhancing excessive mitochondrial fission in dendritic spines. However, a molecular mechanism that leads to the formation of SNO-Cdk5 in neuronal cells remained obscure. Here, we demonstrate that neuronal nitric oxide synthase (NOS1) interacts with Cdk5 and that the close proximity of the two proteins facilitates the formation of SNO-Cdk5. Interestingly, as a negative feedback mechanism, Cdk5 phosphorylates and suppresses NOS1 activity. Thus, together with our previous report, these findings delineate an S-nitrosylation pathway wherein Cdk5/NOS1 interaction enhances SNO-Cdk5 formation, mediating mitochondrial dysfunction and synaptic loss during the etiology of AD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22874667      PMCID: PMC3609065          DOI: 10.4161/pri.21250

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  58 in total

1.  An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator.

Authors:  D Tang; J Yeung; K Y Lee; M Matsushita; H Matsui; K Tomizawa; O Hatase; J H Wang
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

2.  Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene.

Authors:  Victoria H Lawson; Brad V Graham; Kevin M Flanigan
Journal:  Neurology       Date:  2005-07-26       Impact factor: 9.910

3.  Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit.

Authors:  M D Ehlers; S Zhang; J P Bernhadt; R L Huganir
Journal:  Cell       Date:  1996-03-08       Impact factor: 41.582

4.  Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein.

Authors:  R Sattler; Z Xiong; W Y Lu; M Hafner; J F MacDonald; M Tymianski
Journal:  Science       Date:  1999-06-11       Impact factor: 47.728

5.  Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease.

Authors:  Masashi Kitazawa; Salvatore Oddo; Tritia R Yamasaki; Kim N Green; Frank M LaFerla
Journal:  J Neurosci       Date:  2005-09-28       Impact factor: 6.167

6.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

Authors:  L F Lue; Y M Kuo; A E Roher; L Brachova; Y Shen; L Sue; T Beach; J H Kurth; R E Rydel; J Rogers
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

7.  Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.

Authors:  T Ohshima; J M Ward; C G Huh; G Longenecker; H C Pant; R O Brady; L J Martin; A B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.

Authors:  S A Lipton; Y B Choi; Z H Pan; S Z Lei; H S Chen; N J Sucher; J Loscalzo; D J Singel; J S Stamler
Journal:  Nature       Date:  1993-08-12       Impact factor: 49.962

9.  A brain-specific activator of cyclin-dependent kinase 5.

Authors:  J Lew; Q Q Huang; Z Qi; R J Winkfein; R Aebersold; T Hunt; J H Wang
Journal:  Nature       Date:  1994-09-29       Impact factor: 49.962

10.  Proline-directed phosphorylation of human Tau protein.

Authors:  R Vulliet; S M Halloran; R K Braun; A J Smith; G Lee
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

View more
  15 in total

Review 1.  Aberrant protein s-nitrosylation in neurodegenerative diseases.

Authors:  Tomohiro Nakamura; Shichun Tu; Mohd Waseem Akhtar; Carmen R Sunico; Shu-Ichi Okamoto; Stuart A Lipton
Journal:  Neuron       Date:  2013-05-22       Impact factor: 17.173

Review 2.  The Role of Cdk5 in Alzheimer's Disease.

Authors:  Shu-Lei Liu; Chong Wang; Teng Jiang; Lan Tan; Ang Xing; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-07-31       Impact factor: 5.590

Review 3.  Cdk5 activity in the brain - multiple paths of regulation.

Authors:  Kavita Shah; Debomoy K Lahiri
Journal:  J Cell Sci       Date:  2014-06-01       Impact factor: 5.285

Review 4.  Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2015-12-17

Review 5.  S-Nitrosylation in Alzheimer's disease.

Authors:  Qing-Fei Zhao; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-03-25       Impact factor: 5.590

Review 6.  Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases.

Authors:  Meghan C Gage; Thimmasettappa Thippeswamy
Journal:  CNS Drugs       Date:  2021-01-30       Impact factor: 5.749

7.  Anti-diabetes drug pioglitazone ameliorates synaptic defects in AD transgenic mice by inhibiting cyclin-dependent kinase5 activity.

Authors:  Jinan Chen; Shenghua Li; Wenshan Sun; Junrong Li
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

8.  Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure.

Authors:  Edward Rockenstein; Kiren Ubhi; Margarita Trejo; Michael Mante; Christina Patrick; Anthony Adame; Philipp Novak; Marion Jech; Edith Doppler; Herbert Moessler; Eliezer Masliah
Journal:  BMC Neurosci       Date:  2014-07-21       Impact factor: 3.288

9.  Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity.

Authors:  Anna Wilkaniec; Magdalena Gąssowska-Dobrowolska; Marcin Strawski; Agata Adamczyk; Grzegorz A Czapski
Journal:  J Neuroinflammation       Date:  2018-01-04       Impact factor: 8.322

Review 10.  Oxidative stress, mitochondrial damage and neurodegenerative diseases.

Authors:  Chunyan Guo; Li Sun; Xueping Chen; Danshen Zhang
Journal:  Neural Regen Res       Date:  2013-07-25       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.